OTCPK:CSWYY (China)
Â
ADR
$
19.25
(0%)
11:08 PM EST
Business Description
China Shineway Pharmaceutical Group Ltd
ISIN : US16947J1007
Share Class Description:
CSWYY: ADRTotal Employee Number:
2,822Compare
Compare
Traded in other countries / regions
02877.Hong KongC1S.GermanyCSWYF.USA IPO Date
2008-10-13Description
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 22.59 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | 0.26 | |||||
Interest Coverage | 126.96 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.54 | |||||
Beneish M-Score | -2.71 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7.7 | |||||
3-Year EBITDA Growth Rate | 6.5 | |||||
3-Year EPS without NRI Growth Rate | 9.8 | |||||
3-Year FCF Growth Rate | -0.6 | |||||
3-Year Book Growth Rate | 11 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 7.99 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.23 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.71 | |||||
Quick Ratio | 3.43 | |||||
Cash Ratio | 3.01 | |||||
Days Inventory | 308.54 | |||||
Days Sales Outstanding | 101.05 | |||||
Days Payable | 155.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 12 | |||||
3-Year Average Share Buyback Ratio | 3 | |||||
Shareholder Yield % | 8.01 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 72.28 | |||||
Operating Margin % | 22.9 | |||||
Net Margin % | 30.26 | |||||
EBITDA Margin % | 40.63 | |||||
FCF Margin % | 31.1 | |||||
OCF Margin % | 37.41 | |||||
ROE % | 12.3 | |||||
ROA % | 9.2 | |||||
ROIC % | 19.91 | |||||
3-Year ROIIC % | -5.35 | |||||
ROC (Joel Greenblatt) % | 104.42 | |||||
ROCE % | 16.18 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 5.51 | |||||
Forward PE Ratio | 5.17 | |||||
PE Ratio without NRI | 5.38 | |||||
Shiller PE Ratio | 7.93 | |||||
Price-to-Owner-Earnings | 3.77 | |||||
PEG Ratio | 0.42 | |||||
PS Ratio | 1.67 | |||||
PB Ratio | 0.65 | |||||
Price-to-Tangible-Book | 0.66 | |||||
Price-to-Free-Cash-Flow | 5.37 | |||||
Price-to-Operating-Cash-Flow | 4.47 | |||||
EV-to-EBIT | -1.88 | |||||
EV-to-EBITDA | -1.88 | |||||
EV-to-Revenue | -0.76 | |||||
EV-to-FCF | -2.45 | |||||
Price-to-GF-Value | 1.14 | |||||
Price-to-Projected-FCF | 0.35 | |||||
Price-to-Median-PS-Value | 1.03 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.42 | |||||
Price-to-Graham-Number | 0.4 | |||||
| Price-to-Net-Current-Asset-Value | 0.79 | |||||
| Price-to-Net-Cash | 1.07 | |||||
Earnings Yield (Greenblatt) % | -53.19 | |||||
FCF Yield % | 18.6 | |||||
Forward Rate of Return (Yacktman) % | 28.1 |
China Shineway Pharmaceutical Group Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
China Shineway Pharmaceutical Group Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| USD 1.240954 Cash Dividend | 2026-05-05 | 19.25 (+0.00%) | ||
| USD 0.307865 Cash Dividend | 2025-09-10 | 19.25 (+0.00%) | ||
| USD 0.981779 Cash Dividend | 2025-05-02 | 18.53 (+0.00%) | ||
| USD 0.308103 Cash Dividend | 2024-09-11 | 18.53 (+0.00%) |
Show
Entries
Guru Commentaries on OTCPK:CSWYY
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on China Shineway Pharmaceutical Group Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers